| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | actin filament fragmentation | 1.58e-05 | 4 | 34 | 2 | GO:0030043 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex disassembly | 4.18e-05 | 41 | 34 | 3 | GO:0043243 | |
| GeneOntologyBiologicalProcess | establishment of Sertoli cell barrier | 7.34e-05 | 8 | 34 | 2 | GO:0097368 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 8.98e-05 | 144 | 34 | 4 | GO:0043244 | |
| GeneOntologyCellularComponent | nuclear matrix | 7.65e-05 | 140 | 34 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.66e-04 | 171 | 34 | 4 | GO:0034399 | |
| GeneOntologyCellularComponent | Sin3-type complex | 5.81e-04 | 22 | 34 | 2 | GO:0070822 | |
| GeneOntologyCellularComponent | microtubule organizing center | 5.89e-04 | 919 | 34 | 7 | GO:0005815 | |
| Domain | RBB1NT | 3.03e-06 | 2 | 33 | 2 | IPR012603 | |
| Domain | RBB1NT | 3.03e-06 | 2 | 33 | 2 | PF08169 | |
| Domain | ADF/Cofilin | 9.07e-06 | 3 | 33 | 2 | IPR017904 | |
| Domain | Tudor-knot | 4.52e-05 | 6 | 33 | 2 | IPR025995 | |
| Domain | Tudor-knot | 4.52e-05 | 6 | 33 | 2 | PF11717 | |
| Domain | ADF | 1.35e-04 | 10 | 33 | 2 | SM00102 | |
| Domain | Cofilin_ADF | 1.35e-04 | 10 | 33 | 2 | PF00241 | |
| Domain | ADF-H | 1.35e-04 | 10 | 33 | 2 | IPR002108 | |
| Domain | ADF_H | 1.35e-04 | 10 | 33 | 2 | PS51263 | |
| Domain | - | 3.13e-04 | 15 | 33 | 2 | 1.10.150.60 | |
| Domain | ARID | 3.13e-04 | 15 | 33 | 2 | PF01388 | |
| Domain | BRIGHT | 3.13e-04 | 15 | 33 | 2 | SM00501 | |
| Domain | ARID_dom | 3.13e-04 | 15 | 33 | 2 | IPR001606 | |
| Domain | ARID | 3.13e-04 | 15 | 33 | 2 | PS51011 | |
| Domain | BRCT | 5.08e-04 | 19 | 33 | 2 | PF00533 | |
| Domain | BRCT | 6.84e-04 | 22 | 33 | 2 | SM00292 | |
| Domain | - | 7.48e-04 | 23 | 33 | 2 | 3.40.50.10190 | |
| Domain | - | 8.15e-04 | 24 | 33 | 2 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 8.15e-04 | 24 | 33 | 2 | IPR029006 | |
| Domain | BRCT | 9.58e-04 | 26 | 33 | 2 | PS50172 | |
| Domain | TUDOR | 1.03e-03 | 27 | 33 | 2 | SM00333 | |
| Domain | BRCT_dom | 1.11e-03 | 28 | 33 | 2 | IPR001357 | |
| Domain | Tudor | 1.28e-03 | 30 | 33 | 2 | IPR002999 | |
| Domain | Chromodomain-like | 1.45e-03 | 32 | 33 | 2 | IPR016197 | |
| Domain | CHROMO | 1.54e-03 | 33 | 33 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.54e-03 | 33 | 33 | 2 | IPR000953 | |
| Pathway | REACTOME_CELL_CYCLE | 3.19e-05 | 694 | 27 | 8 | M543 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 3.42e-05 | 200 | 27 | 5 | M864 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 6.75e-05 | 561 | 27 | 7 | M5336 | |
| Pathway | REACTOME_CELL_CYCLE | 1.06e-04 | 603 | 27 | 7 | MM14635 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 3.90e-04 | 184 | 27 | 4 | MM15145 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 4.17e-04 | 16 | 27 | 2 | M16498 | |
| Pubmed | EIF5B SRSF11 IGF1R RFC1 CAMSAP2 USO1 LMO7 PRPF40A CFL1 DYNC1H1 CUX1 PPP1R12A HSP90AB1 | 1.08e-10 | 1247 | 35 | 13 | 27684187 | |
| Pubmed | EIF5B SRSF11 CFAP210 CENPF FAM133A CAMSAP2 LMO7 CFL1 CFL2 CUX1 PPP1R12A HSP90AB1 DDX11 | 6.38e-10 | 1442 | 35 | 13 | 35575683 | |
| Pubmed | 7.97e-10 | 191 | 35 | 7 | 20195357 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EIF5B SRSF11 RFC1 ARID4B ARID4A PRPF40A CFL1 CFL2 CUX1 TP53BP1 HSP90AB1 | 1.43e-09 | 954 | 35 | 11 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EIF5B RFC1 ARID4B ARID4A LMO7 USP16 PRPF40A PSMA3 TP53BP1 HSP90AB1 | 3.12e-09 | 774 | 35 | 10 | 15302935 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EIF5B RFC1 USO1 LMO7 PRPF40A CFL1 CFL2 DYNC1H1 PPP1R12A PSMA3 HSP90AB1 | 9.83e-09 | 1149 | 35 | 11 | 35446349 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.01e-08 | 477 | 35 | 8 | 31300519 | |
| Pubmed | 3.03e-08 | 503 | 35 | 8 | 16964243 | ||
| Pubmed | 3.17e-08 | 506 | 35 | 8 | 30890647 | ||
| Pubmed | ADF/cofilin-mediated actin retrograde flow directs neurite formation in the developing brain. | 1.11e-07 | 10 | 35 | 3 | 23259946 | |
| Pubmed | 1.16e-07 | 847 | 35 | 9 | 35850772 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EIF5B ARID4B ARID4A USO1 DYNC1H1 CUX1 PPP1R12A TP53BP1 HSP90AB1 | 1.28e-07 | 857 | 35 | 9 | 25609649 |
| Pubmed | 1.99e-07 | 255 | 35 | 6 | 15324660 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EIF5B RFC1 CAMSAP2 USP16 PRPF40A CFL1 PPP1R12A TP53BP1 HSP90AB1 | 2.64e-07 | 934 | 35 | 9 | 33916271 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EIF5B RFC1 CENPF LMO7 USP16 CFL1 CFL2 DYNC1H1 PPP1R12A HSP90AB1 | 2.95e-07 | 1257 | 35 | 10 | 36526897 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EIF5B SRSF11 POLR1A CENPF LMO7 PRPF40A CFL1 DYNC1H1 HSP90AB1 | 5.69e-07 | 1024 | 35 | 9 | 24711643 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 6.16e-07 | 163 | 35 | 5 | 22113938 | |
| Pubmed | SRSF11 RFC1 FAM133A USO1 LMO7 PRPF40A CFL1 DYNC1H1 PSMA3 HSP90AB1 | 6.54e-07 | 1371 | 35 | 10 | 36244648 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 7.11e-07 | 317 | 35 | 6 | 17620599 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EIF5B RFC1 POLR1A CENPF USO1 PRPF40A CFL1 DYNC1H1 PSMA3 HSP90AB1 | 9.29e-07 | 1425 | 35 | 10 | 30948266 |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24023293 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21894436 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8800436 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30662943 | ||
| Pubmed | Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes. | 9.84e-07 | 2 | 35 | 2 | 18728284 | |
| Pubmed | The ADF/cofilin proteins: stimulus-responsive modulators of actin dynamics. | 9.84e-07 | 2 | 35 | 2 | 8589446 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12049672 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8195165 | ||
| Pubmed | 1.08e-06 | 549 | 35 | 7 | 38280479 | ||
| Pubmed | 1.35e-06 | 191 | 35 | 5 | 33762435 | ||
| Pubmed | 1.95e-06 | 206 | 35 | 5 | 34185411 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.57e-06 | 626 | 35 | 7 | 33644029 | |
| Pubmed | Dephosphorylation of serine 3 regulates nuclear translocation of cofilin. | 2.95e-06 | 3 | 35 | 2 | 8824278 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 29797600 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 34165167 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 26089203 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 26996939 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 23395798 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 18808680 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 11809832 | ||
| Pubmed | HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. | 2.95e-06 | 3 | 35 | 2 | 19683683 | |
| Pubmed | 3.39e-06 | 653 | 35 | 7 | 22586326 | ||
| Pubmed | 3.46e-06 | 655 | 35 | 7 | 35819319 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 3.65e-06 | 949 | 35 | 8 | 36574265 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SRSF11 IGF1R USO1 PRPF40A BARHL1 CFL1 DYNC1H1 PPP1R12A PSMA3 | 3.67e-06 | 1284 | 35 | 9 | 17353931 |
| Pubmed | CIR1 EIF5B SRSF11 RFC1 CFL1 DYNC1H1 PPP1R12A TP53BP1 HSP90AB1 | 3.99e-06 | 1297 | 35 | 9 | 33545068 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 4.01e-06 | 670 | 35 | 7 | 22990118 | |
| Pubmed | 4.07e-06 | 963 | 35 | 8 | 28671696 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EIF5B SRSF11 RFC1 POLR1A USP16 PRPF40A CFL1 DYNC1H1 HSP90AB1 | 4.54e-06 | 1318 | 35 | 9 | 30463901 |
| Pubmed | 5.02e-06 | 250 | 35 | 5 | 33536335 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 5.40e-06 | 701 | 35 | 7 | 30196744 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 5.62e-06 | 1353 | 35 | 9 | 29467282 | |
| Pubmed | ARID4A and ARID4B regulate male fertility, a functional link to the AR and RB pathways. | 5.90e-06 | 4 | 35 | 2 | 23487765 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 22450169 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 17043311 | ||
| Pubmed | Expression of cofilin isoforms during development of mouse striated muscles. | 5.90e-06 | 4 | 35 | 2 | 10813634 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 12684437 | ||
| Pubmed | ADF/Cofilin-Mediated Actin Turnover Promotes Axon Regeneration in the Adult CNS. | 5.90e-06 | 4 | 35 | 2 | 31400829 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 15718469 | ||
| Pubmed | 6.60e-06 | 723 | 35 | 7 | 34133714 | ||
| Pubmed | 7.40e-06 | 124 | 35 | 4 | 35516420 | ||
| Pubmed | 8.73e-06 | 1429 | 35 | 9 | 35140242 | ||
| Pubmed | CAMSAP2 USO1 LMO7 PRPF40A CFL1 CFL2 DYNC1H1 PPP1R12A HSP90AB1 | 8.83e-06 | 1431 | 35 | 9 | 37142655 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 30077770 | ||
| Pubmed | 1.07e-05 | 136 | 35 | 4 | 21280222 | ||
| Pubmed | 1.37e-05 | 809 | 35 | 7 | 32129710 | ||
| Pubmed | Next-generation sequencing to generate interactome datasets. | 1.45e-05 | 1147 | 35 | 8 | 21516116 | |
| Pubmed | Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. | 1.47e-05 | 6 | 35 | 2 | 9655398 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 23969417 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.70e-05 | 153 | 35 | 4 | 26365490 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.84e-05 | 847 | 35 | 7 | 35235311 | |
| Pubmed | 2.03e-05 | 334 | 35 | 5 | 30425250 | ||
| Pubmed | Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation. | 2.06e-05 | 7 | 35 | 2 | 28453519 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.26e-05 | 580 | 35 | 6 | 35676659 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 2.28e-05 | 165 | 35 | 4 | 16107646 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.30e-05 | 582 | 35 | 6 | 20467437 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.32e-05 | 583 | 35 | 6 | 29844126 | |
| Pubmed | DNA damage response in microcephaly development of MCPH1 mouse model. | 2.74e-05 | 8 | 35 | 2 | 23683352 | |
| Pubmed | Identification and characterization of three new components of the mSin3A corepressor complex. | 2.74e-05 | 8 | 35 | 2 | 12724404 | |
| Pubmed | Filamin-A regulates actin-dependent clustering of HIV receptors. | 2.74e-05 | 8 | 35 | 2 | 17572668 | |
| Pubmed | 2.91e-05 | 360 | 35 | 5 | 33111431 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 3.39e-05 | 624 | 35 | 6 | 33729478 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 3.45e-05 | 1294 | 35 | 8 | 30804502 | |
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 18775311 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 31541646 | ||
| Pubmed | 3.73e-05 | 64 | 35 | 3 | 22865885 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 3.96e-05 | 190 | 35 | 4 | 15161933 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 4.38e-05 | 195 | 35 | 4 | 17110338 | |
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 15922553 | ||
| Pubmed | BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. | 4.40e-05 | 10 | 35 | 2 | 16207813 | |
| Pubmed | 4.64e-05 | 660 | 35 | 6 | 32780723 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 4.80e-05 | 400 | 35 | 5 | 35013556 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 4.93e-05 | 989 | 35 | 7 | 36424410 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 5.09e-05 | 1367 | 35 | 8 | 32687490 | |
| Pubmed | 5.31e-05 | 72 | 35 | 3 | 33106477 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 26258622 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 5.38e-05 | 11 | 35 | 2 | 23294842 | |
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 33087478 | ||
| Pubmed | 6.11e-05 | 421 | 35 | 5 | 34650049 | ||
| Pubmed | CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity. | 6.45e-05 | 12 | 35 | 2 | 32839317 | |
| Interaction | ENO1 interactions | EIF5B IKZF3 POLR1A CENPF CFL1 DYNC1H1 PPP1R12A PSMA3 TP53BP1 HSP90AB1 | 1.09e-07 | 701 | 33 | 10 | int:ENO1 |
| Interaction | SMC5 interactions | EIF5B SRSF11 RFC1 ARID4B ARID4A PRPF40A CFL1 CFL2 CUX1 TP53BP1 HSP90AB1 | 3.00e-07 | 1000 | 33 | 11 | int:SMC5 |
| Interaction | BAP1 interactions | EIF5B IGF1R RFC1 USO1 LMO7 PRPF40A CFL1 CFL2 DYNC1H1 PPP1R12A PSMA3 HSP90AB1 | 5.51e-07 | 1314 | 33 | 12 | int:BAP1 |
| Interaction | CAP2 interactions | 4.00e-06 | 66 | 33 | 4 | int:CAP2 | |
| Interaction | DBN1 interactions | 4.14e-06 | 417 | 33 | 7 | int:DBN1 | |
| Interaction | ARRB2 interactions | 7.23e-06 | 454 | 33 | 7 | int:ARRB2 | |
| Interaction | YWHAQ interactions | IGF1R RFC1 CAMSAP2 USO1 LMO7 CFL1 DYNC1H1 PPP1R12A PSMA3 HSP90AB1 | 7.60e-06 | 1118 | 33 | 10 | int:YWHAQ |
| Interaction | ECT2 interactions | 8.84e-06 | 887 | 33 | 9 | int:ECT2 | |
| Interaction | PPIA interactions | 8.92e-06 | 888 | 33 | 9 | int:PPIA | |
| Interaction | OBSL1 interactions | EIF5B SRSF11 RFC1 POLR1A CBLB CENPF PRPF40A DYNC1H1 HSP90AB1 | 1.01e-05 | 902 | 33 | 9 | int:OBSL1 |
| Interaction | PINK1 interactions | 1.05e-05 | 679 | 33 | 8 | int:PINK1 | |
| Interaction | CEBPB interactions | EIF5B SRSF11 RFC1 USO1 PRPF40A CFL1 DYNC1H1 CUX1 PSMA3 TP53BP1 HSP90AB1 | 1.08e-05 | 1443 | 33 | 11 | int:CEBPB |
| Interaction | CIT interactions | EIF5B POLR1A CENPF LMO7 PRPF40A CFL1 CFL2 DYNC1H1 CUX1 PPP1R12A HSP90AB1 | 1.13e-05 | 1450 | 33 | 11 | int:CIT |
| Interaction | SPOP interactions | 1.20e-05 | 491 | 33 | 7 | int:SPOP | |
| Interaction | ACTC1 interactions | 1.23e-05 | 694 | 33 | 8 | int:ACTC1 | |
| Interaction | MAD2L2 interactions | 1.29e-05 | 325 | 33 | 6 | int:MAD2L2 | |
| Interaction | PRC1 interactions | EIF5B CENPF LMO7 PRPF40A CFL1 CFL2 DYNC1H1 PPP1R12A HSP90AB1 | 1.85e-05 | 973 | 33 | 9 | int:PRC1 |
| Interaction | NAA40 interactions | EIF5B RFC1 CAMSAP2 USP16 PRPF40A CFL1 PPP1R12A TP53BP1 HSP90AB1 | 1.93e-05 | 978 | 33 | 9 | int:NAA40 |
| Interaction | FGD5 interactions | 2.05e-05 | 207 | 33 | 5 | int:FGD5 | |
| Interaction | SMARCC2 interactions | 2.06e-05 | 353 | 33 | 6 | int:SMARCC2 | |
| Interaction | NFIC interactions | 2.19e-05 | 210 | 33 | 5 | int:NFIC | |
| Interaction | CRK interactions | 2.68e-05 | 370 | 33 | 6 | int:CRK | |
| Interaction | FOXK2 interactions | 3.05e-05 | 225 | 33 | 5 | int:FOXK2 | |
| Interaction | DDX39B interactions | 3.14e-05 | 570 | 33 | 7 | int:DDX39B | |
| Interaction | PARP1 interactions | IKZF3 RFC1 POLR1A ARID4B USO1 LMO7 PRPF40A CUX1 TP53BP1 HSP90AB1 | 3.15e-05 | 1316 | 33 | 10 | int:PARP1 |
| Interaction | FOLR1 interactions | 3.18e-05 | 227 | 33 | 5 | int:FOLR1 | |
| Interaction | RUVBL1 interactions | 3.32e-05 | 575 | 33 | 7 | int:RUVBL1 | |
| Interaction | BIRC3 interactions | EIF5B RFC1 POLR1A CENPF USO1 PRPF40A CFL1 DYNC1H1 PSMA3 HSP90AB1 | 3.54e-05 | 1334 | 33 | 10 | int:BIRC3 |
| Interaction | DOT1L interactions | 3.64e-05 | 807 | 33 | 8 | int:DOT1L | |
| Interaction | CDK1 interactions | 3.92e-05 | 590 | 33 | 7 | int:CDK1 | |
| Interaction | HDAC1 interactions | 5.16e-05 | 1108 | 33 | 9 | int:HDAC1 | |
| Interaction | MYO19 interactions | 5.24e-05 | 252 | 33 | 5 | int:MYO19 | |
| Interaction | NR2C2 interactions | EIF5B SRSF11 RFC1 POLR1A USP16 PRPF40A CFL1 DYNC1H1 TP53BP1 HSP90AB1 | 5.45e-05 | 1403 | 33 | 10 | int:NR2C2 |
| Interaction | HDLBP interactions | 5.48e-05 | 855 | 33 | 8 | int:HDLBP | |
| Interaction | ERLEC1 interactions | 5.51e-05 | 128 | 33 | 4 | int:ERLEC1 | |
| Interaction | HDAC2 interactions | 5.95e-05 | 865 | 33 | 8 | int:HDAC2 | |
| Interaction | CUL1 interactions | 6.50e-05 | 876 | 33 | 8 | int:CUL1 | |
| Interaction | EED interactions | EIF5B IGF1R ARID4B CBLB USO1 PRPF40A CFL1 DYNC1H1 TP53BP1 HSP90AB1 | 6.99e-05 | 1445 | 33 | 10 | int:EED |
| Interaction | FLNA interactions | 7.09e-05 | 648 | 33 | 7 | int:FLNA | |
| Interaction | WIF1 interactions | 8.94e-05 | 145 | 33 | 4 | int:WIF1 | |
| Interaction | GAPDH interactions | 1.01e-04 | 686 | 33 | 7 | int:GAPDH | |
| Interaction | CDK4 interactions | 1.05e-04 | 292 | 33 | 5 | int:CDK4 | |
| Interaction | RNF113A interactions | 1.07e-04 | 692 | 33 | 7 | int:RNF113A | |
| Interaction | CSNK2A1 interactions | 1.20e-04 | 956 | 33 | 8 | int:CSNK2A1 | |
| Interaction | YWHAG interactions | SRSF11 IGF1R CAMSAP2 LMO7 PRPF40A CFL1 DYNC1H1 PPP1R12A HSP90AB1 | 1.29e-04 | 1248 | 33 | 9 | int:YWHAG |
| Interaction | BRCA1 interactions | EIF5B RFC1 POLR1A CENPF FAM133A USO1 DYNC1H1 TP53BP1 HSP90AB1 | 1.30e-04 | 1249 | 33 | 9 | int:BRCA1 |
| Interaction | ISG15 interactions | 1.33e-04 | 494 | 33 | 6 | int:ISG15 | |
| Interaction | CSNK2A2 interactions | 1.35e-04 | 718 | 33 | 7 | int:CSNK2A2 | |
| Interaction | LRRK2 interactions | 1.36e-04 | 496 | 33 | 6 | int:LRRK2 | |
| Interaction | POLR1C interactions | 1.41e-04 | 311 | 33 | 5 | int:POLR1C | |
| Interaction | HERC2 interactions | 1.47e-04 | 503 | 33 | 6 | int:HERC2 | |
| Interaction | MAPRE1 interactions | 1.65e-04 | 514 | 33 | 6 | int:MAPRE1 | |
| Interaction | CHAF1A interactions | 1.66e-04 | 322 | 33 | 5 | int:CHAF1A | |
| Interaction | HDAC4 interactions | 1.68e-04 | 744 | 33 | 7 | int:HDAC4 | |
| Interaction | SIRT7 interactions | 1.68e-04 | 744 | 33 | 7 | int:SIRT7 | |
| Interaction | CTNNB1 interactions | 1.74e-04 | 1009 | 33 | 8 | int:CTNNB1 | |
| Interaction | TES interactions | 1.91e-04 | 332 | 33 | 5 | int:TES | |
| Interaction | PHLPP1 interactions | 1.94e-04 | 333 | 33 | 5 | int:PHLPP1 | |
| Interaction | KIF23 interactions | 2.02e-04 | 1031 | 33 | 8 | int:KIF23 | |
| Interaction | SAP130 interactions | 2.10e-04 | 181 | 33 | 4 | int:SAP130 | |
| Interaction | FBXO22 interactions | 2.15e-04 | 540 | 33 | 6 | int:FBXO22 | |
| Interaction | B3GNT2 interactions | 2.20e-04 | 542 | 33 | 6 | int:B3GNT2 | |
| Interaction | CAPZB interactions | 2.27e-04 | 1049 | 33 | 8 | int:CAPZB | |
| Interaction | CDK2 interactions | 2.30e-04 | 783 | 33 | 7 | int:CDK2 | |
| Interaction | SND1 interactions | 2.35e-04 | 347 | 33 | 5 | int:SND1 | |
| Interaction | BTF3 interactions | 2.60e-04 | 799 | 33 | 7 | int:BTF3 | |
| Interaction | TUBB4B interactions | 2.62e-04 | 560 | 33 | 6 | int:TUBB4B | |
| Interaction | SYNPO interactions | 2.63e-04 | 192 | 33 | 4 | int:SYNPO | |
| Interaction | DCTN2 interactions | 2.64e-04 | 356 | 33 | 5 | int:DCTN2 | |
| Interaction | TSHZ1 interactions | 2.69e-04 | 15 | 33 | 2 | int:TSHZ1 | |
| Interaction | SFPQ interactions | 2.70e-04 | 563 | 33 | 6 | int:SFPQ | |
| Interaction | TOLLIP interactions | 2.71e-04 | 358 | 33 | 5 | int:TOLLIP | |
| Interaction | SKA3 interactions | 2.74e-04 | 194 | 33 | 4 | int:SKA3 | |
| Interaction | SSH1 interactions | 2.91e-04 | 79 | 33 | 3 | int:SSH1 | |
| Interaction | KCTD13 interactions | CAMSAP2 USO1 LMO7 PRPF40A CFL1 CFL2 DYNC1H1 PPP1R12A HSP90AB1 | 2.98e-04 | 1394 | 33 | 9 | int:KCTD13 |
| Interaction | PAX6 interactions | 3.00e-04 | 366 | 33 | 5 | int:PAX6 | |
| Interaction | GATA2 interactions | 3.02e-04 | 199 | 33 | 4 | int:GATA2 | |
| Interaction | LDHA interactions | 3.36e-04 | 375 | 33 | 5 | int:LDHA | |
| Interaction | ZNF451 interactions | 3.36e-04 | 83 | 33 | 3 | int:ZNF451 | |
| Interaction | SLFN11 interactions | 3.40e-04 | 376 | 33 | 5 | int:SLFN11 | |
| Interaction | TENT5A interactions | 3.48e-04 | 84 | 33 | 3 | int:TENT5A | |
| Interaction | IQGAP1 interactions | 3.50e-04 | 591 | 33 | 6 | int:IQGAP1 | |
| Interaction | SMARCC1 interactions | 3.74e-04 | 384 | 33 | 5 | int:SMARCC1 | |
| Interaction | KCNA3 interactions | 4.38e-04 | 871 | 33 | 7 | int:KCNA3 | |
| Interaction | H2BC3 interactions | 4.83e-04 | 406 | 33 | 5 | int:H2BC3 | |
| Interaction | DDX46 interactions | 4.96e-04 | 227 | 33 | 4 | int:DDX46 | |
| Interaction | TESK2 interactions | 5.31e-04 | 97 | 33 | 3 | int:TESK2 | |
| Interaction | CBX3 interactions | 5.61e-04 | 646 | 33 | 6 | int:CBX3 | |
| Interaction | NPM1 interactions | 5.66e-04 | 1201 | 33 | 8 | int:NPM1 | |
| Interaction | WWTR1 interactions | 5.75e-04 | 422 | 33 | 5 | int:WWTR1 | |
| Interaction | HSP90B1 interactions | 5.79e-04 | 650 | 33 | 6 | int:HSP90B1 | |
| Interaction | SIRPA interactions | 5.80e-04 | 100 | 33 | 3 | int:SIRPA | |
| Interaction | HEXIM1 interactions | 5.81e-04 | 913 | 33 | 7 | int:HEXIM1 | |
| Interaction | POT1 interactions | 5.84e-04 | 237 | 33 | 4 | int:POT1 | |
| Interaction | U2AF2 interactions | 5.84e-04 | 651 | 33 | 6 | int:U2AF2 | |
| Interaction | UBE2I interactions | 5.98e-04 | 654 | 33 | 6 | int:UBE2I | |
| Interaction | TNIP1 interactions | 6.18e-04 | 1217 | 33 | 8 | int:TNIP1 | |
| Interaction | MDM2 interactions | 6.18e-04 | 658 | 33 | 6 | int:MDM2 | |
| Interaction | POLQ interactions | 6.44e-04 | 23 | 33 | 2 | int:POLQ | |
| Interaction | UNC5CL interactions | 6.44e-04 | 23 | 33 | 2 | int:UNC5CL | |
| Cytoband | 2q31.1 | 1.89e-03 | 84 | 35 | 2 | 2q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q23 | 4.45e-03 | 130 | 35 | 2 | chr14q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q31 | 8.18e-03 | 178 | 35 | 2 | chr2q31 | |
| GeneFamily | AT-rich interaction domain containing | 1.47e-04 | 15 | 22 | 2 | 418 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 4.09e-07 | 534 | 35 | 8 | MM1054 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 5.01e-06 | 523 | 35 | 7 | M12707 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 6.63e-06 | 200 | 35 | 5 | M4456 | |
| Coexpression | ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR | 9.54e-06 | 100 | 35 | 4 | M39218 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.35e-05 | 856 | 35 | 8 | M4500 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 1.72e-05 | 116 | 35 | 4 | M2379 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 1.77e-05 | 117 | 35 | 4 | MM931 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | 1.93e-05 | 644 | 35 | 7 | M10501 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 2.44e-05 | 444 | 35 | 6 | M41713 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | 2.92e-05 | 687 | 35 | 7 | M41022 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | 3.41e-05 | 281 | 35 | 5 | M4077 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 3.98e-05 | 721 | 35 | 7 | M10237 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN | 6.60e-05 | 323 | 35 | 5 | M12570 | |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 7.30e-05 | 168 | 35 | 4 | M6874 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | 7.80e-05 | 547 | 35 | 6 | M2110 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 9.08e-05 | 822 | 35 | 7 | M6782 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.14e-04 | 363 | 35 | 5 | M41103 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 1.43e-04 | 200 | 35 | 4 | M7505 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 1.52e-04 | 203 | 35 | 4 | MM3795 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 1.90e-04 | 644 | 35 | 6 | M41717 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 2.18e-04 | 417 | 35 | 5 | M39224 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 3.09e-04 | 705 | 35 | 6 | M1410 | |
| Coexpression | EIF4E_DN | 3.23e-04 | 100 | 35 | 3 | M2790 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 3.36e-04 | 458 | 35 | 5 | M40010 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 3.63e-04 | 466 | 35 | 5 | M13522 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | EIF5B SRSF11 RFC1 ARID4B ARID4A CENPF USP16 PRPF40A CUX1 TP53BP1 HSP90AB1 | 2.42e-06 | 1257 | 34 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | EIF5B SRSF11 RFC1 ARID4B ARID4A CENPF USP16 PRPF40A CUX1 TP53BP1 HSP90AB1 | 1.02e-05 | 1459 | 34 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_500 | 3.45e-05 | 116 | 34 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_200 | 3.56e-05 | 40 | 34 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.19e-05 | 629 | 34 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.68e-05 | 432 | 34 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 1.30e-04 | 163 | 34 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.92e-04 | 339 | 34 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.89e-04 | 201 | 34 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.00e-04 | 203 | 34 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.05e-04 | 375 | 34 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_100 | 3.33e-04 | 17 | 34 | 2 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 4.55e-04 | 94 | 34 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 4.70e-04 | 412 | 34 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_500 | 6.46e-04 | 106 | 34 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_500 | 7.30e-04 | 25 | 34 | 2 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.74e-04 | 261 | 34 | 4 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 8.00e-04 | 983 | 34 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | 8.00e-04 | 983 | 34 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | 8.30e-04 | 989 | 34 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 8.30e-04 | 989 | 34 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.44e-04 | 469 | 34 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.54e-07 | 188 | 35 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.46e-07 | 197 | 35 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.69e-07 | 199 | 35 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.69e-07 | 199 | 35 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.69e-07 | 199 | 35 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 4.69e-07 | 199 | 35 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.69e-07 | 199 | 35 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.18e-05 | 180 | 35 | 4 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.34e-05 | 186 | 35 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 187 | 35 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 188 | 35 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-05 | 191 | 35 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.52e-05 | 192 | 35 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 193 | 35 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 1.55e-05 | 193 | 35 | 4 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-05 | 193 | 35 | 4 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.65e-05 | 196 | 35 | 4 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-05 | 196 | 35 | 4 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.68e-05 | 197 | 35 | 4 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.68e-05 | 197 | 35 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.71e-05 | 198 | 35 | 4 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.71e-05 | 198 | 35 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.75e-05 | 199 | 35 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.75e-05 | 199 | 35 | 4 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.75e-05 | 199 | 35 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.75e-05 | 199 | 35 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.75e-05 | 199 | 35 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.75e-05 | 199 | 35 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 150 | 35 | 3 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 150 | 35 | 3 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 151 | 35 | 3 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-04 | 169 | 35 | 3 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 3.23e-04 | 171 | 35 | 3 | dfd4a15ab68ef5a9a1954b1b1540ae04017885a6 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 173 | 35 | 3 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 173 | 35 | 3 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | 758a1796b823118ce52f989ef5e1076f8c8ac4c5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 178 | 35 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.69e-04 | 179 | 35 | 3 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 181 | 35 | 3 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 181 | 35 | 3 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.00e-04 | 184 | 35 | 3 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.19e-04 | 187 | 35 | 3 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.26e-04 | 188 | 35 | 3 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 4.33e-04 | 189 | 35 | 3 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 4.39e-04 | 190 | 35 | 3 | 4225bfa10a6fb909a3ba8ac26f3541c390b46737 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 4.39e-04 | 190 | 35 | 3 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Severe-Lymphoid-T-NK|Severe / Condition, Lineage, Cell class and cell subclass | 4.39e-04 | 190 | 35 | 3 | 60642de433f84fa2cecd796c3a1a4aab9219d3db | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.46e-04 | 191 | 35 | 3 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.46e-04 | 191 | 35 | 3 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4|Lung / Manually curated celltypes from each tissue | 4.53e-04 | 192 | 35 | 3 | fd19cd0b5330448bef8debd753285adbc8b958a2 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 041124dd5c24c1eb188d2560ba606422c0b215c5 | |
| ToppCell | droplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | d9e61b2722aa81e4f6e11865a04f2f1e75b794ab | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.53e-04 | 192 | 35 | 3 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.53e-04 | 192 | 35 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | ILEUM-inflamed-(1)_Th17_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.60e-04 | 193 | 35 | 3 | 0663c57e1b8b8dd70d617d029fc7bdbbda8c1208 | |
| ToppCell | COVID-19_Convalescent-CD4+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 4.60e-04 | 193 | 35 | 3 | 346caaf288217acaf232060629ce964a07f63432 | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 4.60e-04 | 193 | 35 | 3 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | Healthy/Control-CD4+_T_naive|Healthy/Control / Disease group and Cell class | 4.60e-04 | 193 | 35 | 3 | f5face746df3517c86d72e31ba8f1b78c4c6b481 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | 07ddb9525b686c31fa7df4286557d1e58f7ead52 | |
| ToppCell | Healthy/Control-CD4+_T_naive|World / Disease group and Cell class | 4.60e-04 | 193 | 35 | 3 | 6218e6cbe44d92bb98d42ef2f5e18ab7a683b100 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 4.67e-04 | 194 | 35 | 3 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-04 | 194 | 35 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.67e-04 | 194 | 35 | 3 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.67e-04 | 194 | 35 | 3 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_activated|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.67e-04 | 194 | 35 | 3 | e3f288b58525c1f34db4459d3e83e0df695adfc7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.67e-04 | 194 | 35 | 3 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.74e-04 | 195 | 35 | 3 | 4e114f6399863406bd87220dea7fb7dfd08824bd | |
| ToppCell | mild-dn_T|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.74e-04 | 195 | 35 | 3 | 158f0f229bad71cc9b06b7399168982bbbbd1d47 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.74e-04 | 195 | 35 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.74e-04 | 195 | 35 | 3 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.81e-04 | 196 | 35 | 3 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Severe-Lymphoid-T-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 4.81e-04 | 196 | 35 | 3 | 29d4db6816fead2ad9136ef824e0775463b02159 | |
| ToppCell | COVID-19-Epithelial_cells-Cycling_epithelial|COVID-19 / group, cell type (main and fine annotations) | 4.81e-04 | 196 | 35 | 3 | ac55fff652bad06eab502645bf64126625763ab3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.81e-04 | 196 | 35 | 3 | c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04 | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.81e-04 | 196 | 35 | 3 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.81e-04 | 196 | 35 | 3 | 17f17edadafdad9f24e88d708d7e1c765503131c | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.88e-04 | 197 | 35 | 3 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Severe / Disease group, lineage and cell class | 4.88e-04 | 197 | 35 | 3 | 07f74bdadfd28e1d55b3f4a3bf87d5dd65a2e9c5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.88e-04 | 197 | 35 | 3 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.88e-04 | 197 | 35 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.88e-04 | 197 | 35 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.88e-04 | 197 | 35 | 3 | 258dfe69b5faeaee709422f873b144ca5e4a6452 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.88e-04 | 197 | 35 | 3 | 268ca646f4a7466709c2c8b6ca56cf1344f3ef3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.88e-04 | 197 | 35 | 3 | 59b1fb93a39dcf8c994d2b7dc2906dae74c57527 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.88e-04 | 197 | 35 | 3 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.88e-04 | 197 | 35 | 3 | 9f0d91bb7aec4f2442259eca1ddf7905f8d40e9b | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.88e-04 | 197 | 35 | 3 | 9a3d0b7f4788487d024d56bc776a2fd1149f50d5 | |
| ToppCell | BL-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.88e-04 | 197 | 35 | 3 | fb70918867fbd111bb192a797dcafed5f39ea299 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.88e-04 | 197 | 35 | 3 | bf80e39cd68fd5bb85c8726d4f82648391de74ad | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.88e-04 | 197 | 35 | 3 | 296b27348ca7e9acf746f752cf810e4e5baea76c | |
| ToppCell | COVID-19_Severe-CD4+_T_naive|COVID-19_Severe / Disease condition and Cell class | 4.88e-04 | 197 | 35 | 3 | ac26672bd2cb3bc9a11206d8da203bafec3931f6 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.88e-04 | 197 | 35 | 3 | cf72160f03105876641fa6fdc7405e339eb084c7 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.88e-04 | 197 | 35 | 3 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.88e-04 | 197 | 35 | 3 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Control-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.88e-04 | 197 | 35 | 3 | 925bf0d38e4ce279fa45f455546ebd199282c0df | |
| ToppCell | BL-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.95e-04 | 198 | 35 | 3 | 1c0227e58a64c0bf509bfb9578fb91277316b120 | |
| ToppCell | Sigmoid-T_cell-Treg|T_cell / Region, Cell class and subclass | 4.95e-04 | 198 | 35 | 3 | e2d2f9f209f77d0c48cfe3e9902c0ae0795511b2 | |
| ToppCell | Caecum-T_cell-Tcm|T_cell / Region, Cell class and subclass | 4.95e-04 | 198 | 35 | 3 | f889ee80c641540fd8db9eaefcd16aa51ddb2c01 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.95e-04 | 198 | 35 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.48e-04 | 49 | 23 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Air Pollutants | 5.67e-06 | 917 | 34 | 9 | ctd:D000393 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 5.72e-06 | 174 | 34 | 5 | 7530_DN | |
| Drug | Lovastatin | 1.46e-05 | 211 | 34 | 5 | ctd:D008148 | |
| Drug | NSC226080 | 1.53e-05 | 782 | 34 | 8 | CID000005040 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.97e-05 | 801 | 32 | 7 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 4.54e-04 | 29 | 32 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | response to angiotensin receptor blocker | 4.86e-04 | 30 | 32 | 2 | EFO_0010735 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 7.01e-04 | 36 | 32 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 9.22e-04 | 1074 | 32 | 6 | C0006142 | |
| Disease | insulin resistance | 1.88e-03 | 59 | 32 | 2 | EFO_0002614 | |
| Disease | alcohol consumption measurement | 1.94e-03 | 1242 | 32 | 6 | EFO_0007878 | |
| Disease | Mammary Carcinoma, Human | 2.40e-03 | 525 | 32 | 4 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.40e-03 | 525 | 32 | 4 | C1257931 | |
| Disease | Microcephaly | 2.41e-03 | 67 | 32 | 2 | C0025958 | |
| Disease | JT interval | 2.43e-03 | 248 | 32 | 3 | EFO_0007885 | |
| Disease | Mammary Neoplasms | 2.43e-03 | 527 | 32 | 4 | C1458155 | |
| Disease | Breast Carcinoma | 2.62e-03 | 538 | 32 | 4 | C0678222 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.69e-03 | 257 | 32 | 3 | DOID:10652 (is_marker_for) | |
| Disease | Endometrial Carcinoma | 2.78e-03 | 72 | 32 | 2 | C0476089 | |
| Disease | serum gamma-glutamyl transferase measurement | 2.83e-03 | 914 | 32 | 5 | EFO_0004532 | |
| Disease | psychotic symptoms | 2.93e-03 | 74 | 32 | 2 | EFO_0005940 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDTDYEEDEVTKKRK | 791 | Q4LE39 | |
| DATYETKESKKEDLV | 86 | P23528 | |
| KDVDDDYETAEKKEN | 501 | P29374 | |
| DSEYKVKEEGDREIS | 151 | Q9BZE3 | |
| YLEKEREKEISDDEA | 216 | P08238 | |
| SESDYEEDVQAKKKR | 196 | Q8N9E0 | |
| KTKYDEETTAKADEI | 226 | Q13948 | |
| EKTRDPVEEDDDEYK | 696 | Q13191 | |
| DATYETKESKKEDLV | 86 | Q9Y281 | |
| EAEKQAEKEEAEYRK | 706 | P08069 | |
| SYTSDLQKKKEEREE | 751 | Q8WWI1 | |
| AKENERKTSDEVYDE | 1126 | A8MYU2 | |
| EYESDEEKKVASRVD | 201 | Q96FC9 | |
| VQTEKEEKEEARSKY | 446 | O75400 | |
| EEKEEARSKYKEAKE | 451 | O75400 | |
| LKETLEEKTKEADEY | 2846 | P49454 | |
| SFKEDEEESKEDRKL | 846 | Q5T1B0 | |
| SDTEYREKEEKKEGS | 436 | Q6ZRK6 | |
| DEDDLAYAETEKKTR | 4351 | Q14204 | |
| KDEYSERDENVLKSE | 61 | Q9UKT9 | |
| EEEKRSSDSDYEQAK | 51 | Q5H9B9 | |
| NKVTIDDYREEDEDK | 801 | Q01668 | |
| DEKVYTDRAKEKESQ | 821 | Q08AD1 | |
| KAIYKSSEEDKKEEE | 626 | O60763 | |
| KRKEKQEEEVDYESE | 1416 | O95602 | |
| KKKRIIYDSDSESEE | 61 | P35251 | |
| DDDRTKEERAYDKAK | 596 | O60841 | |
| EEEEERRKKYEEKDA | 226 | Q0VFZ6 | |
| ENKEKEETEGETEYK | 81 | Q86X95 | |
| EEEKDNDSYIKERSD | 416 | Q9Y5T5 | |
| DEEEQGYDSEKEKKE | 426 | Q05519 | |
| AEKYAKESLKEEDES | 236 | P25788 | |
| RLDTKEEKSVEYEGD | 801 | Q12888 | |
| ETSKDEKVVKSEDYE | 471 | Q9NRE2 | |
| ITDEDKKKSTKDRYD | 341 | Q9P0L1 | |
| EEKKESETSREDEYK | 741 | O14974 |